Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in J Immunol

Retrieve available abstracts of 7 articles:
HTML format

Single Articles

    February 2023
  1. SUBRAMANIAN K, Paul S, Libby A, Patterson J, et al
    HERV1-env Induces Unfolded Protein Response Activation in Autoimmune Liver Disease: A Potential Mechanism for Regulatory T Cell Dysfunction.
    J Immunol. 2023 Feb 1:ji2100186. doi: 10.4049/jimmunol.2100186.
    PubMed     Abstract available

    June 2022
  2. LIU Y, Qin L, Wang J, Xie X, et al
    miR-146a Maintains Immune Tolerance of Kupffer Cells and Facilitates Hepatitis B Virus Persistence in Mice.
    J Immunol. 2022;208:2558-2572.
    PubMed     Abstract available

    January 2022
  3. WANG X, Liang Y, Wang H, Zhang B, et al
    The Protective Role of IL-36/IL-36R Signal in Con A-Induced Acute Hepatitis.
    J Immunol. 2022 Jan 19. pii: jimmunol.2100481. doi: 10.4049/jimmunol.2100481.
    PubMed     Abstract available

  4. LI W, Duan X, Zhu C, Liu X, et al
    Hepatitis B and Hepatitis C Virus Infection Promote Liver Fibrogenesis through a TGF-beta1-Induced OCT4/Nanog Pathway.
    J Immunol. 2022 Jan 12. pii: jimmunol.2001453. doi: 10.4049/jimmunol.2001453.
    PubMed     Abstract available

    August 2021
  5. MAZOUZ S, Boisvert M, Abdel-Hakeem MS, Khedr O, et al
    Expansion of Unique Hepatitis C Virus-Specific Public CD8(+) T Cell Clonotypes during Acute Infection and Reinfection.
    J Immunol. 2021 Aug 2. pii: jimmunol.2001386. doi: 10.4049/jimmunol.2001386.
    PubMed     Abstract available

    April 2021
  6. BARRIOCANAL M, Prior C, Suarez B, Unfried JP, et al
    Long Noncoding RNA EGOT Responds to Stress Signals to Regulate Cell Inflammation and Growth.
    J Immunol. 2021;206:1932-1942.
    PubMed     Abstract available

    January 2021
  7. RODRIGUEZ-GARCIA E, Zabaleta N, Gil-Farina I, Gonzalez-Aparicio M, et al
    AdrA as a Potential Immunomodulatory Candidate for STING-Mediated Antiviral Therapy That Required Both Type I IFN and TNF-alpha Production.
    J Immunol. 2021;206:376-385.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.